New Evidence in GvHD Prophylaxis for Unrelated Donor Stem Cell Transplantation

The DKMS has published a press release on the GRAPPA study, presented as a Late-Breaking Abstract at the European Hematology Association (EHA) Congress 2026 in Stockholm. Reference: Stelljes M. et al. GVHD prophylaxis including ATG remains standard of care for HLA-compatible unrelated donor hematopoietic cell transplantation: Results from a large randomized controlled trial comparing ATG […]

Rapperswil (Switzerland), January 2nd 2026: Dr. Christian Loss, Chief Executive Officer (CEO) of Neovii Pharmaceuticals AG, will take a well-deserved retirement after his distinguished career at Neovii. As of January, he is succeeded by Frédéric Prince PhD, who most recently served as Head of Strategy and Chief of Staff ad interim to the Head of […]

Neovii and Fosun Pharma Enter into an Exclusive Agreement for Development and Commercialization for Grafalon in China (September 7, 2022, Rapperswil, Switzerland and Shanghai, China) Neovii Pharmaceuticals AG (“Neovii”), a Swiss based global specialty-care biopharmaceutical company, and Shanghai Fosun Pharmaceutical Industry Development Co. Ltd (“Fosun Pharma Industry”), a subsidiary of Shanghai Fosun Pharmaceutical (Group) Co., […]